High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.
Abstract
The rise of antimalarial drug-resistant Plasmodium falciparum threatens malaria elimination efforts. Mutations in the gene kelch13 ( k13 ) confer artemisinin partial resistance (ART-R), compromising the efficacy of frontline artemisinin-based combination therapies (ACTs). The validated mutation k13 R622I has emerged and expanded rapidly in the Horn of Africa. We conducted a year-long genomic surveillance study in Gondar Zuria and Tach Armachiho, two ecologically distinct districts in northwestern Ethiopia where R622I was first identified. A total of 903 P. falciparum infections were sequenced using molecular inversion probe (MIP) panels targeting major drug resistance mutations and genome-wide informative SNPs. The R622I mutation was found in 44.3% of samples, more frequent in Gondar Zuria than Tach Armachiho (52% vs. 35%; p < 0.001 ), and persisted year-round in nearly all sites, indicating stable transmission with minimal seasonal variation. Histidine-rich protein 2 (HRP2) based rapid diagnostic test (RDT) negativity was also prevalent (39.3%), with significant district-level variation (48.7% vs. 27.6%; p < 0.001 ). Concerningly, R622I and HRP2-RDT co-occured in 22% of samples, higher in Gondar Zuria than in Tach Armachiho (28.9% vs. 12.9%; p < 0.00 1). Overall, HRP2-RDT negativity was significantly more common among R622I mutant parasites than wild-type (48.3% vs. 30.7%; p < 0.05). The k13 C580Y mutation was also detected at very low frequency (0.4%) in Gondar Zuria, representing the first report of this mutation in the Horn of Africa. Long-read whole-genome sequencing showed k13 flanking haplotypes of C580Y isolates were distinct from Southeast Asian lineages, suggesting a local, de novo emergence of African origin. These findings highlight the increasing prevalence and types of ART-R mutations, persistence of k13 R622I and its increasing association with HRP2-RDT negativity, representing a double threat to malaria control and elimination efforts.
Overview
CoChat Summary
TL;DR
In a year-long genomic surveillance study in two districts of northwestern Ethiopia, k13 R622I was found in 44.3% of successfully typed P. falciparum infections and HRP2-based RDT negativity in 39.3%, with co-occurrence in 22.0%. R622I was more common in Gondar Zuria than Tach Armachiho, persisted year-round, and was associated with higher RDT negativity; two C580Y cases were also detected and appeared locally emergent.
Key findings
- k13 R622I was detected in 369/833 successfully typed samples (44.3%, 95% CI 40.9–47.7), significantly higher in Gondar Zuria (51.5%, 95% CI 46.9–56.0) than Tach Armachiho (35.4%, 95% CI 30.5–40.3; p < 0.001), and was found in all but one Kebele.
- HRP2-based RDT negativity occurred in 39.3% (317/807) of microscopy-confirmed infections, higher in Gondar Zuria (48.7%) than Tach Armachiho (27.6%; p < 0.001); R622I and RDT negativity co-occurred in 22.0% overall (28.9% vs. 12.9%; p = 0.001), and RDT negativity was more common among R622I mutants than wild-type parasites (48.3% vs. 30.7%; p < 0.05).
- Two k13 C580Y cases were detected in Gondar Zuria (reported as 0.4% in the abstract and section 2.3, but 0.2% in section 2.2), representing the first report in Ethiopia/Horn of Africa; long-read WGS showed a flanking haplotype distinct from Southeast Asian lineages, suggesting local de novo emergence, and both infections were HRP2-RDT negative with no reads mapping to hrp2 or hrp3.
- R622I persisted year-round, peaking at 60.5% in March overall, and mutants showed higher identity-by-descent than wild-type parasites in Gondar Zuria (0.369 vs. 0.234; p = 3.29e-8) and Tach Armachiho (0.249 vs. 0.172; p = 3.55e-3); RDT-negative R622I infections had higher IBD than RDT-positive R622I infections (0.365 vs. 0.284; p < 0.001).
Methods
- Health-facility-based cross-sectional genomic surveillance from November 1, 2022 to October 31, 2023 in Gondar Zuria and Tach Armachiho districts, Amhara region, northwest Ethiopia; 903 microscopy-confirmed P. falciparum infections were enrolled (500 from Gondar Zuria, 403 from Tach Armachiho), with mean age 22.1 ± 13.0 years and 59.4% male.
- Dried blood spots were used for DNA extraction; molecular inversion probe (MIP) panels targeted major drug resistance genes (k13, mdr1, crt, dhfr, dhps) and genome-wide informative SNPs (2,128 MIPs), sequenced on Illumina NextSeq 550; analyses included drug resistance prevalence, linkage disequilibrium, complexity of infection, identity-by-descent, and relatedness networks.
- Long-read Oxford Nanopore Technology whole-genome sequencing after selective whole-genome amplification was performed on two k13 C580Y samples; flanking haplotypes were compared with 41 publicly available Southeast Asian C580Y parasites, and rainfall data were obtained from CHIRPS.
Limitations
- The paper states that a major limitation is the use of RDT negativity as a clinical surrogate for pfhrp2/3 gene deletions in microscopy-confirmed cases, without molecular typing of pfhrp2/3, so individual deletion status is not resolved; it also states that data from a single year limit assessment of temporal trends in seasonality.
- Evident from the text: RDT results were missing for 96/903 participants (10.6%), so RDT analyses use 807 participants; C580Y frequency is reported inconsistently (0.2% in section 2.2 vs. 0.4% in the abstract and section 2.3); and the health-facility-based sampling may not fully represent community transmission.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
0 Valid · 0 Not valid · 20 Not checked · 79 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although monthly differences were not statistically significant (Mann–Kendall trend test, p > 0.05; S10A and S10B Fig)”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.7 Monthly prevalence and clonality of k13 R622I
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“more frequent in Gondar Zuria than Tach Armachiho (52% vs. 35%; p < 0.001)”
- Also stated in: § 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity · plain
“The prevalence of R622I was significantly (Student’s t-test p < 0.001) higher in Gondar Zuria district (highland with lower malaria transmission) (51.5%, 95% CI 46.9-56.0%) compared to Tach Armachiho (lowland with higher malaria transmission) (35.4%, 95% CI 30.5-40.3%)”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > Abstract
plainn = 833 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The R622I mutation was found in 44.3% of samples”
- Also stated in: § 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity · plain
“The validated k13 R622I mutation was found in 369/833 samples (44.3%, 95% CI 40.9-47.7%)”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > Abstract
plainn = 833- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutation was identified in all but one Kebele (Fig 1C and S3 Table) across both districts suggesting broad spread of this mutation at local scale.”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The flanking haplotype based on the long-reads from the more deeply sequenced sample was distinct from those in SEA based on comparison to 41 representative publicly-available SEA C580Y parasites [31]”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.3 Detection of k13 C580Y mutation in Ethiopia
What the sources say
- Not checked yetcites [31] MalariaGEN, 2023, Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples, Wellcome Open Res source
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
59 more claims
Create a free account to see all 99 claims and to verify the 30 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Age in years | 5-17 | 142(28.4) | 183(45.4%) | 359 (39.8%) |”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.1 Study population
Reported 359 · recomputed 325
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.2 Prevalence and Local Spread of k13 R622I and HRP2-RDT negativity
“The mutation was identified in all but one Kebele (Fig 1C and S3 Table) across both districts suggesting broad spread of this mutation at local scale.”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 3. Discussion
“Our data reveal a steep and alarming rise in the k13 R622I mutation prevalence in northern western Ethiopia compared to previous years, reaching 44% overall and detected in all surveyed Kebeles.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Gametocyte | Positive | 19(3.8%) | 20(5.0%) | 39 (4.4%) |”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.1 Study population
Reported 4.4 · recomputed 4.318937
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Age in years | ≥18 | 355(71.0%) | 213(52.9%) | 534 (59.1%) |”
§ High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia > 2. Results > 2.1 Study population
Reported 534 · recomputed 568
Citations
Cites
Funk, C., Peterson, P., Landsfeld, M., Pedreros, D., Verdin, J., Shukla, S., Husak, G., Rowland, J., Harrison, L., Hoell, A., et al. (2015) · Scientific Data · doi:10.1038/sdata.2015.66 · Cited by 6,362
Haplotype-based variant detection from short-read sequencing
Garrison, E., & Marth, G. (2012) · arXiv · doi:10.48550/arxiv.1207.3907 · Cited by 3,700
UpSetR: an R package for the visualization of intersecting sets and their properties
Conway, J. R., Lex, A., & Gehlenborg, N. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx364 · Cited by 3,586
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Uwimana, A., Legrand, E., Stokes, B. H., Ndikumana, J.-L. M., Warsame, M., Umulisa, N., Ngamije, D., Munyaneza, T., Mazarati, J.-B., Munguti, K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1005-2 · Cited by 831
Anderson, T. J. C., Haubold, B., Williams, J. T., Estrada-Franco§, J. G., Richardson, L., Mollinedo, R., Bockarie, M., Mokili, J., Mharakurwa, S., French, N., et al. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026247 · Cited by 779
Artemisinin-Based Combination Treatment of Falciparum Malaria
Nosten, F., & White, N. J. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.181 · Cited by 673
Cited by
Fola, A. A., Ciubotariu, I. I., Dorman, J., Mwenda, M., Mambwe, B., Mulube, C., Kasaro, R., Hawela, M. B., Hamainza, B., Miller, J. M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-45996-y · Cited by 6
Self-citationChala, B., Platon, L., Tibiri, Y. N. G., Strubel, P.-E., Thiebaut, L., Wade, A., Caspar, E., Muller, A., Bastien, M., Nigussie, H., et al. (2026) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(26)00301-4 · Cited by 4
Bohissou, F. E. T., Nassa, G. J. W., Inoue, J., Sondo, P., Rouamba, T., Yessinou, J., Held, J., & Tinto, H. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14233-2 · Cited by 1
Osborne, A. A., Assefa, A., Degaga, T. S., Hailu, A., Woyessa, A., Tadesse, D., Rai, A., Rumaseb, A., Trimarsanto, H., Kwiatkowski, D. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.19.700308 · Cited by 1
Self-citationCavros, I., Kpemasse, A., Maye, A. S. Y., Saliou, R., Kpanou, S., Houndjo, W., Aïssan, J., Affoukou, C. D., Yamonmi, D., Affoukou, M., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-05857-5 · Cited by 1
Metadata
- Authors
- Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., Kiyuka, P., Parr, J. B., Hailu, A., Tegegne, M. A., & Bailey, J. A.
- Affiliations
- University of Gondar (ET)
- Brown University (US)
- Ethiopian Public Health Institute (ET)
- University of North Carolina at Chapel Hill (US)
- Kenya Medical Research Institute (KE)
- Addis Ababa University (ET)
- Corresponding author
- Zeleke, Ayalew Jejaw
- ORCID
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2025-12-11
- Volume
- 21
- Issue
- 12
- Pages
- e1013771
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC12697994
- OpenAlex
- W4417251261
- Cited by
- 12
- References
- 76
- Citations by year
- 2026: 12
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Pathogens (publishedVersion, public-domain)
- medRxiv (submittedVersion, cc-by-nc)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc)
- PubMed (submittedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UNC Libraries
- Funders
- European Union (CSA 2020NOE-3102)
- NIH (R01AI177791)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- Plasmodium falciparum, artemisinin resistance, antimalarial drug resistance, long-read whole-genome sequencing, northern Ethiopia, Horn of Africa, molecular surveillance
- MeSH terms
- Adolescent, Adult, Antigens, Protozoan, Antimalarials, Child, Child, Preschool, Diagnostic Tests, Routine, Drug Resistance, Ethiopia, Female, Humans, Infant, Male, Mutation, Plasmodium falciparum, Protozoan Proteins, Prevalence, Malaria, Falciparum, Polymorphism, Single Nucleotide, Artemisinins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.